
Journal Menu
► ▼ Journal Menu-
- ncRNA Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Topical Collections
- Article Processing Charge
- Indexing & Archiving
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Awards
ncRNA 2022 Outstanding Reviewer Award
Dear Colleagues,
On behalf of the Editor-in-Chief, Prof. Dr. George A Calin, we would like to acknowledge our reviewers who generously offer their time to review the papers submitted to Non-Coding RNA by introducing an award for reviewers who have demonstrated their dedication, professionalism, and timeliness in reviewing manuscripts for the journal.
What are the requirements to be eligible for this award?
All of the reviewers for Non-Coding RNA in 2022 will be automatically included.
Selection Criteria:
– Number of review reports;
– The quality and timeliness of review reports.
What will the winners receive?
There will be two winners this year, and each will receive the following:
– CHF 300;
– The opportunity to publish a paper free of charge in Non-Coding RNA after peer review in 2023;
– A certificate.
When will the winners be announced?
The winners will be announced on 30 March 2023 on the journal website.
How can I make myself eligible?
If you have not yet reviewed papers for Non-Coding RNA, but would like to do so, you can register as a reviewer at the following link: https://susy.mdpi.com/volunteer/profile/edit.
Kind regards,
ncRNA Editorial Office
Closed Awards
ncRNA 2019 Travel Award
Dear Colleagues,
As Editor-in-Chief of Non-Coding RNA (ncRNA), it is my great pleasure to announce that the winner of the 2019 ncRNA Travel Award is Mr. Baptiste Bogard, MS. He is a second-year PhD student in Dr. Florent Hubé’s laboratory in the Epigénétique et Destin Cellulaire, CNRS UMR7216, Université Paris Diderot, Paris, France. ncRNA will support Mr. Baptiste with 800 Swiss Francs for travel expenses.
Additional details are available here:
https://www.mdpi.com/journal/ncrna/awards.
Prof. Dr. George A. Calin
Editor-in-Chief
Non-Coding RNA (ISSN 2311-553X) is an open access journal published by MDPI AG, Basel, Switzerland. ncRNA maintains a rigorous peer-review and a rapid publication process.
ncRNA 2018 Best Poster Award at FASEB SRC
Dear Colleagues,
The journal Non-Coding RNA (ISSN 2311-553X) offered a Best Poster Award at the FASEB SRC meeting “Posttranscriptional Control of Gene Expression: Mechanisms of RNA Decay”, which was held 24–29 June 2018 in Scottsdale, AZ, USA. All attendees with a poster presentation on non-coding RNAs were eligible.
Dr. Anthony Mustoe from the University of North Carolina (Chapel Hill, NC, USA) is the winner of this award and received a prize of 200 Swiss Francs. Dr. Mustoe showed his findings in a poster presentation entitled “Pervasive Regulatory Functions of Bacterial mRNA Structure Revealed by High-Resolution SHAPE Probing”.
Best Regards,
Non-Coding RNA Editorial Office
ncRNA 2018 Travel Award
Dear Colleagues,
As Editor-in-Chief of the Non-coding RNA Journal (ncRNA), on behalf of the Travel Award 2018 Committee, it is my pleasure to announce that the winner of the 2018 ncRNA Travel Award is Dr. Cristian Rodriguez-Aguayo. Dr. Cristian Rodriguez-Aguayo an Instructor at the Department of Experimental Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. His current research focuses on the understanding of the functional basis and biological mechanism by RBPs and non-coding RNAs promote cancer growth and tumor progression. He has co-authored more than 70 papers published in international peer-reviewed journals, he also has patents and book chapters.
On behalf of ncRNA, Dr. Rodriguez-Aguayo will be awarded 800 Swiss Francs to attend the TAT 2018 – Targeted Anticancer Therapies meeting that will be held 5– 7 March, 2018 in Paris, France. There, he will present his work on “Regulation of hnRNPA1 by microRNAs controls the miR-18a–KRAS axis in chemotherapy-resistant ovarian cancer”
Prof. Dr. George A. Calin,
Editor-in-Chief